Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MRI vastus lateralis fat fraction predicts loss of ambulation in Duchenne muscular dystrophy
Karin J. Naarding, Harmen Reyngoudt, Erik W. van Zwet, et al.
Neurology (2020) Vol. 94, Iss. 13
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Wearable full-body motion tracking of activities of daily living predicts disease trajectory in Duchenne muscular dystrophy
Valeria Ricotti, Balasundaram Kadirvelu, V. Selby, et al.
Nature Medicine (2023) Vol. 29, Iss. 1, pp. 95-103
Open Access | Times Cited: 46
Expression of SRP-9001 dystrophin and stabilization of motor function up to 2 years post-treatment with delandistrogene moxeparvovec gene therapy in individuals with Duchenne muscular dystrophy
Jerry R. Mendell, Perry B. Shieh, Craig M. McDonald, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 43
Delandistrogene Moxeparvovec Gene Therapy in Ambulatory Patients (Aged ≥4 to <8 Years) with Duchenne Muscular Dystrophy: 1‐Year Interim Results from Study SRP‐9001‐103 (ENDEAVOR)
Craig M. Zaidman, Crystal M. Proud, Craig M. McDonald, et al.
Annals of Neurology (2023) Vol. 94, Iss. 5, pp. 955-968
Open Access | Times Cited: 38
Predictors of Loss of Ambulation in Duchenne Muscular Dystrophy: A Systematic Review and Meta-Analysis
Erik Landfeldt, Alicia Alemán, Sophia Abner, et al.
Journal of Neuromuscular Diseases (2024) Vol. 11, Iss. 3, pp. 579-612
Open Access | Times Cited: 7
Overview of MR Image Segmentation Strategies in Neuromuscular Disorders
Augustin C. Ogier, Marc‐Adrien Hostin, Marc‐Emmanuel Bellemare, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 40
Longitudinal study of MRI and functional outcome measures in facioscapulohumeral muscular dystrophy
Leo H. Wang, Dennis Shaw, Anna Faino, et al.
BMC Musculoskeletal Disorders (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 37
Three‐year quantitative magnetic resonance imaging and phosphorus magnetic resonance spectroscopy study in lower limb muscle in dysferlinopathy
Harmen Reyngoudt, Fiona E. Smith, Ericky Caldas de Almeida Araújo, et al.
Journal of Cachexia Sarcopenia and Muscle (2022) Vol. 13, Iss. 3, pp. 1850-1863
Open Access | Times Cited: 23
263rd ENMC International Workshop: Focus on female carriers of dystrophinopathy: refining recommendations for prevention, diagnosis, surveillance, and treatment. Hoofddorp, The Netherlands, 13-15 May 2022
Anna Sárközy, Rosaline C. M. Quinlivan, John Bourke, et al.
Neuromuscular Disorders (2023) Vol. 33, Iss. 3, pp. 274-284
Open Access | Times Cited: 16
Quantitative magnetic resonance imaging measures as biomarkers of disease progression in boys with Duchenne muscular dystrophy: a phase 2 trial of domagrozumab
Sarah P. Sherlock, Jeffrey Palmer, Kathryn R. Wagner, et al.
Journal of Neurology (2022) Vol. 269, Iss. 8, pp. 4421-4435
Open Access | Times Cited: 19
Givinostat for Becker muscular dystrophy: A randomized, placebo-controlled, double-blind study
Giacomo P. Comi, Erik H. Niks, Krista Vandenborne, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 11
The feasibility of quantitative MRI of extra‐ocular muscles in myasthenia gravis and Graves' orbitopathy
Kevin R. Keene, Luc van Vught, Nienke M. van de Velde, et al.
NMR in Biomedicine (2020) Vol. 34, Iss. 1
Open Access | Times Cited: 30
Global versus individual muscle segmentation to assess quantitative MRI-based fat fraction changes in neuromuscular diseases
Harmen Reyngoudt, Benjamin Marty, Jean‐Marc Boisserie, et al.
European Radiology (2020) Vol. 31, Iss. 6, pp. 4264-4276
Closed Access | Times Cited: 30
Quantitative Muscle Mri Biomarkers in Duchenne Muscular Dystrophy: Cross-Sectional Correlations with Age and Functional Tests
Sarah P. Sherlock, Yao Zhang, Michael Binks, et al.
Biomarkers in Medicine (2021) Vol. 15, Iss. 10, pp. 761-773
Open Access | Times Cited: 24
Quantitative Muscle Analysis in FSHD Using Whole-Body Fat-Referenced MRI
Michelle Mellion, Per Widholm, Markus Karlsson, et al.
Neurology (2022) Vol. 99, Iss. 9
Open Access | Times Cited: 19
The utility of muscle magnetic resonance imaging in idiopathic inflammatory myopathies: a scoping review
Julie J. Paik, Lisa Christopher‐Stine, Mikael Boesen, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Influence of imaging method on fat fraction estimation for assessing bone marrow in metastatic prostate cancer
Yassine N Azma, Nada Boci, Katarzyna Abramowicz, et al.
European Radiology (2025)
Open Access
Longitudinal Follow‐Up of Patients With Duchenne Muscular Dystrophy Using Quantitative 23Na and 1H MRI
Teresa Gerhalter, Benjamin Marty, Lena V. Gast, et al.
Journal of Cachexia Sarcopenia and Muscle (2025) Vol. 16, Iss. 2
Open Access
Quantitative Muscle Magnetic Resonance Outcomes in Patients With Duchenne Muscular Dystrophy
Krista Vandenborne, Glenn A. Walter, Volker Straub, et al.
JAMA Neurology (2025)
Closed Access
Selection Approach to Identify the Optimal Biomarker Using Quantitative Muscle MRI and Functional Assessments in Becker Muscular Dystrophy
Nienke M. van de Velde, Melissa T. Hooijmans, Aashley S. D. Sardjoe Mishre, et al.
Neurology (2021) Vol. 97, Iss. 5
Open Access | Times Cited: 22
Water-Fat Separation in MR Fingerprinting for Quantitative Monitoring of the Skeletal Muscle in Neuromuscular Disorders
Benjamin Marty, Harmen Reyngoudt, Jean‐Marc Boisserie, et al.
Radiology (2021) Vol. 300, Iss. 3, pp. 652-660
Closed Access | Times Cited: 22
Prospective Natural History Study in 24 Adult Patients With LGMDR12 Over 2 Years of Follow-up
Bram De Wel, Lotte Huysmans, Ronald Peeters, et al.
Neurology (2022) Vol. 99, Iss. 6
Closed Access | Times Cited: 16
Multivariate modeling of magnetic resonance biomarkers and clinical outcome measures for Duchenne muscular dystrophy clinical trials
Sarah Kim, Rebecca J. Willcocks, Michael J. Daniels, et al.
CPT Pharmacometrics & Systems Pharmacology (2023) Vol. 12, Iss. 10, pp. 1437-1449
Open Access | Times Cited: 9
Correlation analysis of quantitative MRI measurements of thigh muscles with histopathology in patients with idiopathic inflammatory myopathy
Fengdan Wang, Shiyuan Fang, Jia Li, et al.
European Radiology Experimental (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 9
Draft Guidance for Industry Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and Related Dystrophinopathies – Developing Potential Treatments for the Entire Spectrum of Disease
Craig M. McDonald, Eric Camino, Rafael Escandon, et al.
Journal of Neuromuscular Diseases (2024) Vol. 11, Iss. 2, pp. 499-523
Open Access | Times Cited: 3
The unconditioned fear response in vertebrates deficient in dystrophin
Saba Gharibi, Cyrille Vaillend, Angus Lindsay
Progress in Neurobiology (2024) Vol. 235, pp. 102590-102590
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top